GC To Depart Cancer Diagnostic Co. NeoGenomics
Cancer diagnostics company NeoGenomics Inc.'s top attorney is set to transition from her role next month and depart the company Oct. 2, according to a securities filing Tuesday....To view the full article, register now.
Already a subscriber? Click here to view full article